Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure

about

Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.

P2860

Q45852989-5F91E30E-247B-4F2B-8F75-31F04E228D7F

P2860

Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure

Item

http://www.wikidata.org/entity/Q36529070

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pleiotropic effects of long-te ...... gs with moderate heart failure

@ast

Pleiotropic effects of long-te ...... gs with moderate heart failure

@en

type

Item

label

Pleiotropic effects of long-te ...... gs with moderate heart failure

@ast

Pleiotropic effects of long-te ...... gs with moderate heart failure

@en

prefLabel

Pleiotropic effects of long-te ...... gs with moderate heart failure

@ast

Pleiotropic effects of long-te ...... gs with moderate heart failure

@en

P1476

Pleiotropic effects of long-te ...... gs with moderate heart failure

@en

P2093

Hani N Sabbah

http://www.w3.org/2001/XMLSchema#string

Ramesh C Gupta

http://www.w3.org/2001/XMLSchema#string

Sharad Rastogi

http://www.w3.org/2001/XMLSchema#string

Sudhish Mishra

http://www.w3.org/2001/XMLSchema#string

Valerio Zacà

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac regulation by phosphoinositide 3-kinases and PTEN

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Rosuvastatin in older patients with systolic heart failure.

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

P304

160-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000342082

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232915162

http://www.w3.org/2001/XMLSchema#string

P698

23128666

http://www.w3.org/2001/XMLSchema#string

P932

3544002

http://www.w3.org/2001/XMLSchema#string

Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure

about

P2860

P2860

Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932